Celerion Acquires Early Stage Clinical Research Operations from MDS Pharma Services

Article

Company News Release

Celerion, a privately owned contract research organization (CRO), has completed the acquisition of the development and regulatory services consultancy and early stage development operations of MDS Pharma Services. The acquired assets include five clinical research facilities and two bioanalytical laboratories located in Lincoln, Nebraska; Neptune, New Jersey; Phoenix, Arizona; Zurich, Switzerland; and Belfast, Northern Ireland, as well as operations in Richmond, Virginia and Quebec, Canada.

Life sciences and CRO industry veteran Susan Thornton, Ph.D., is Chief Executive Officer of Celerion. “I'm energized by the prospect of taking this great business to the next level of market leadership,” she said. “We look forward to continuing to provide our pharmaceutical, biotechnology and generic clients with early stage clinical research services. Like the company I am leading, my roots are in MDS Pharma Services.”

 

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Related Content
© 2024 MJH Life Sciences

All rights reserved.